We re-evaluated the data from this study to investigate the associations of opacification with patient, surgical, and lens-related factors. Data were gathered through a review of medical records, patient interview, and examination.
Data from 215 patients who had Hydroview lenses implanted in Bristol were analysed: 125 had clear lenses, 89 had evidence of opacification, and 1 lens could not be assessed. No statistically significant association was demonstrated between opacification and any of the patient- (Tables 1 and 2 ) or surgery-related factors (Table 3) tested. However, this is likely to be a result of the small number of patients at subgroup analysis level.
There was a marked association of opacification with certain runs of consecutive lens serial numbers (Table 4) . Serial numbers relate only to the order in which the lenses are manufactured and are sequential. Our study will have selection bias, as all patients had surgery over a similar time period and those symptomatic would be more likely to enrol. There will be a high number of certain runs of serial numbers and a high number of opacified lenses. However, variation in the proportion of lenses opacified (3-79%) across the serial numbers tested strongly suggests an association between opacity and certain runs of serial numbers.
Although these data must be viewed with respect to the context, ie, as a retrospective observation rather than as prospective evidence, they do question the supposition that the sole cause for opacification was the silicon gasket. The findings support a manufacturerelated cause over a patient-or surgical-related cause for opacification. Although no conclusions can be drawn about the nature of this unknown aetiological factor, our data pinpoint it within a narrow time frame of manufacture.
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Eye ( Sir, Effect of lyophilization on the in vitro biological activity of bevacizumab Intravitreal bevacizumab has been effective for vascular endothelial growth factor (VEGF)-mediated diseases of the retina and choroids.
1,2,3 However, repeated injections may be required. An alternative mode of administration would be a biodegradable intravitreal implant 4 of lyophilized bevacizumab, which has not been previously reported.
In an effort to assess the viability of a biodegradable intravitreal implant of lyophilized bevacizumab, we a The total number includes one lens of which the opacity could not be assessed and also another lens of which serial number was unknown.
